Results 121 to 130 of about 2,314,750 (241)

To assess whether anti-mullerian hormone varies between women of different race/ethnic backgrounds

, 2016
Author(s) Pre or Post Print Version Only. No PDFIntroduction: Anti-Mullerian hormone, secreted by the granulosa cells in the ovary, is used as an estimate of ovarian reserve and to predict the ovarian response to ovarian stimulation during assisted ...
Nayini, Krishnaveni, Jayaprakasan, Kanna, Korrapati, Siva   +2 more
core   +1 more source

Anti-Müllerian hormone, testicular descent and cryptorchidism

Frontiers in Endocrinology
Anti-Müllerian hormone (AMH) is a Sertoli cell-secreted glycoprotein involved in male fetal sex differentiation: it provokes the regression of Müllerian ducts, which otherwise give rise to the Fallopian tubes, the uterus and the upper part of the vagina.
Rodolfo A. Rey, Rodolfo A. Rey, Rodolfo A. Rey, Romina P. Grinspon   +3 more
doaj   +1 more source

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion

Nature Communications, 2016
Anti-Müllerian hormone (AMH) plays a role in sexual differentiation and gonadal function, but extra-gonadal effects of AMH are not known. Here Cimino et al.
Irene Cimino, Filippo Casoni, Xinhuai Liu, Andrea Messina, Jyoti Parkash, Soazik P. Jamin, Sophie Catteau-Jonard, Francis Collier, Marc Baroncini, Didier Dewailly, Pascal Pigny, Mel Prescott, Rebecca Campbell, Allan E. Herbison, Vincent Prevot, Paolo Giacobini   +15 more
doaj   +1 more source

Delayed menopausal transition in polycystic ovary syndrome: A call for research on age‐dependent phenotypes and different ethnic populations

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Johanna Lavi, Maarit Niinimäki, Terhi Piltonen   +2 more
wiley   +1 more source

Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks

Experimental Physiology, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan, Stephanie Cowan, Chau Thien Tay, Lisa J. Moran, Ashley H. Ng   +4 more
wiley   +1 more source

Expression of anti-Mullerian hormone receptor on the appendix testis in connection with urological disorders

, 2013
The female internal sex organs develop from the paramesonephric (Mullerian) duct. In male embryos, the regression of the Mullerian duct is caused by the anti-Mullerian hormone (AMH), which plays an important role in the process of testicular descent. The
Kistamás, K, Józsa, Tamás, Dienes, B, Telek, A, Kistamás, Kornél, Telek, Andrea, Kosztka, Lívia, Kosztka, L, Csernoch, L, Kovács, Ilona, Ruzsnavszky, O, Józsa, T, Dienes, Beatrix, Ruzsnavszky, Olga, Csernoch, László, Kovács, I   +15 more
core   +1 more source

Supplementary files: Anti-Mullerian hormone levels in female cancer patients of reproductive age in Indonesia: a cross-sectional study

, 2020
These are our supplementary files for Anti-Mullerian hormone levels in female cancer patients of reproductive age in Indonesia: a cross-sectional ...
Achmad Kemal (7311377)
core   +1 more source

Oocyte–cumulus cell interaction: a key factor in early embryo development

Biological Reviews, Volume 101, Issue 5, Page 2265-2278, October 2026.
ABSTRACT The evaluation of oocyte competence is a fundamental step in achieving successful outcomes following assisted reproduction techniques (ART). At present, however, conventional oocyte maturation assessment is carried out by morphological observation, which is a subjective method that does not consider molecular features.
Marc Torres‐Garrido, Marc Yeste, Yentel Mateo‐Otero   +2 more
wiley   +1 more source

Efficacy and safety of pulsatile GnRH pump therapy in male infants with congenital hypogonadotropic hypogonadism

Endocrine Connections
Introduction: To investigate the efficacy and safety of pulsatile gonadotropin-releasing hormone pump therapy in male infants with congenital hypogonadotropic hypogonadism.
Xi Wang, Zi Xia Zhang, Jiajia Chen, Dongxia Fu, Mengmeng Du, Yongxing Chen, Haiyan Wei   +6 more
doaj   +1 more source

The Spectrum of Congenital Hypogonadotropic Hypogonadism: A 30‐Year Experience at a Tertiary Paediatric Centre

Clinical Endocrinology, Volume 105, Issue 4, Page 464-473, October 2026.
ABSTRACT Congenital hypogonadotropic hypogonadism (CHH) is a rare group of disorders of gonadotropin deficiency, either isolated or as a part of multiple pituitary hormone deficiencies (MPHD). We aimed to describe the spectrum of presentation, diagnosis, and management practices of CHH spanning 30 years at an Australian tertiary paediatric centre. This
Minha Kook, Richard G. McGee, Geoffrey Ambler, Yoon Hi Cho   +3 more
wiley   +1 more source